The cost-of-living crisis is having a huge impact on fertility patients, making the sector ripe for disruption. A fertility expert tells HBI cunning new entrants will be the winners while established PE could well be the losers.
A shortage of high-quality healthcare workers in Europe is causing countries to recruit from a more global pool. The Danish government is partnering with India and the Philippines, and HBI hears LATAM could be the new hotspot from which foreign workers will be enlisted in future.
After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
With a recent survey announcing 49% of fertility patients questioned are suspending their treatments, three fertility experts tell HBI it’s becoming increasingly difficult to attract patients. Meanwhile, fertility group TFP looks no closer to sale.
Watch this exclusive interview with Richard Banks, chief strategy officer and European managing director of global fertility company Virtus Health, as he shares valuable insights into the evolving market landscape.
Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
In this wide ranging interview we discuss the future of remote patient monitoring (RPM) software and government progress in ehealth. Through its RPM platform, Huma claims to massively cut costs and improve outcomes for patients with chronic conditions.
Rising costs from inflation, wages, and energy are indiscriminately hitting the health care sector and despite government support packages being pledged, the road ahead looks arduous. So how do providers control costs, and what are the strategies to keep costs at bay?
Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
Australia-based fertility specialist Virtus Health has a new showpiece clinic in Copenhagen. HBI hears it is targeting both locals and medical tourists, and speaks to a source to find out more about the appeal of the Danish market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy